| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |